U.S. Plans to Shift Bill for Covid Shots and Treatments to Insurers, Patients

August 19, 2022

(Wall Street Journal) – Shifting payments for Covid-19 drugs and vaccines to the commercial market is expected to take months, an HHS spokesman said. At the meeting this month, officials and company representatives are expected to discuss reimbursement and coverage, regulatory issues and access to vaccines and treatment for the uninsured. (Read More)